Erosive vulvovaginal lichen planus (EVLP) is a chronic and painful genital dermatosis. Little is published about its impact on quality of life. This study aimed to evaluate quality of life and sexual function in women with EVLP.
Women with genital dermatoses were surveyed using the Dermatology Life Quality Index (DLQI) and Hospital Depression and Anxiety Scales. A subgroup completed the Female Sexual Distress Scale and Female Sexual Function Index subscales. Patient characteristics including age, diagnosis, and current treatment were recorded. Results from women with EVLP were compared with other diagnoses.
Data from 77 women who participated between March 2013 and March 2014 were analyzed. Of these, 17 had EVLP. Comparator groups included women with vulval lichen sclerosus (n = 48) and vulval dermatitis (n = 12). In women with EVLP, 59% reported at least moderate impact on quality of life; mean DLQI scores: EVLP, 7.18; lichen sclerosus, 3.79; dermatitis, 8.67; p = .008. Overall, scores suggested depression in 14% and anxiety in 16% of participants. Sexual distress scores 11 or higher were recorded by 69% of women with EVLP, 63% of women with lichen sclerosus, and 56% of women with dermatitis. In those completing all sections of the survey (n = 40), DLQI was significantly correlated with depression (p = .004), sexual distress (p = .001), and sexual satisfaction (p = .01).
Sixty-nine percent of women with EVLP reported sexual distress. Women with EVLP reported lesser quality of life than those with lichen sclerosus. Quality of life, anxiety and depression, sexual distress, and sexual function were all related in these participants.
Sixty-nine percent of women with erosive vulvovaginal lichen planus reported sexual distress; their quality of life was less than in women with lichen sclerosus.
1Department of Dermatology, Waikato Hospital, Hamilton, New Zealand; and 2Waikato Clinical Campus, University of Auckland, Hamilton, New Zealand
Correspondence to: Helen M. Conaglen, PhD, PGDipPsych(Clin), Waikato Clinical Campus, University of Auckland Faculty of Medical and Health Sciences, Private Bag 3200, Hamilton 3240, New Zealand. E-mail: firstname.lastname@example.org
Supported by Waikato Medical Research Trust (WMRF216, 2013).
The authors have declared they have no conflicts of interest.
An institutional review board approval is not deemed necessary by New Zealand Health and Disability Ethics Committee.